CD4 and leukemia: A clinical study of adoptive cell therapy for leukemia found that CD4+ CAR-T dominated the late CAR-T cell population (more than 95%) which persisted for up to 10 years, and single-cell analysis showed that these long-lived CD4+ CAR-T cells exhibited cytotoxicity characteristics and sustained functional activation and proliferation (52).